Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances Shuai ShaoGang WangJohann E. Gudjonsson Leading Article 16 March 2020 Pages: 525 - 534
Advances in Long-Acting Agents for the Treatment of HIV Infection Aadia I. RanaJose R. Castillo-MancillaRaphael L. Landovitz Leading Article 16 March 2020 Pages: 535 - 545
A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain Harrison DermerDaniella Lent-SchochetAnat Galor Review Article 23 March 2020 Pages: 547 - 571
Potential for Harm Associated with Discharge Opioids After Hospital Stay: A Systematic Review Gerardo A. ArwiStephan A. Schug Systematic Review 11 April 2020 Pages: 573 - 585
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial Mala DharmalingamS. R. AravindHanmant Barkate Original Research Article Open access 11 March 2020 Pages: 587 - 600
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer Connie KangYahiya Y. Syed Adis Drug Evaluation 04 April 2020 Pages: 601 - 607
Tislelizumab: First Approval Arnold LeeSusan J. Keam AdisInsight Report 18 March 2020 Pages: 617 - 624